AP5Z1 affects hepatocellular carcinoma growth and autophagy by regulating PTEN ubiquitination and modulating the PI3K/Akt/mTOR pathway

Abstract Background Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, with high incidence and mortality rates, and the number of cases is expected to increase by 2030. Understanding the molecular mechanisms of HCC and identifying new therapeutic targets and biomarkers for...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhipeng Quan, Bo Peng, Kai Hu, Lixing Liang, Mingjiang Liu, Lijuan Liao, Shilian Chen, Jing Qin, Songqing He, Zeyuan Li
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-025-06537-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850268936801615872
author Zhipeng Quan
Bo Peng
Kai Hu
Lixing Liang
Mingjiang Liu
Lijuan Liao
Shilian Chen
Jing Qin
Songqing He
Zeyuan Li
author_facet Zhipeng Quan
Bo Peng
Kai Hu
Lixing Liang
Mingjiang Liu
Lijuan Liao
Shilian Chen
Jing Qin
Songqing He
Zeyuan Li
author_sort Zhipeng Quan
collection DOAJ
description Abstract Background Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, with high incidence and mortality rates, and the number of cases is expected to increase by 2030. Understanding the molecular mechanisms of HCC and identifying new therapeutic targets and biomarkers for HCC are crucial. Methods In this study, we examined adaptor-related protein complex 5 subunit ζ1 (AP5Z1) expression in liver cancer and nearby noncancerous tissues to explore its effects on HCC cell growth, death, and autophagy. The functional and molecular mechanisms of AP5Z1 were studied using clinical sample analysis, Western blot (WB), immunohistochemistry (IHC), quantitative reverse-transcription polymerase chain reaction (qRT‒PCR), coimmunoprecipitation (Co-IP), cell proliferation assays, flow cytometry (FCM), autophagy assays, electron microscopy, mass spectrometry (MS), transcriptome analysis, and animal model experiments. Results AP5Z1 expression was notably higher in HCC tissues than in normal tissues and was linked to a poor prognosis. The results of both in vitro and in vivo studies revealed that AP5Z1 promoted HCC cell growth and reduced apoptosis. In addition, AP5Z1 regulates cellular autophagy by ubiquitinating the phosphatase and tensin homolog (PTEN) protein and modulating the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway. Conclusions AP5Z1 influences autophagy and apoptosis in HCC cells by interacting with PTEN to modulate the PI3K/Akt/mTOR pathway. This gene might promote PTEN ubiquitination and degradation by recruiting tripartite motif-containing protein 21 (TRIM21), making it a potential biomarker for diagnosing and predicting the outcome of HCC as well as a target for new treatment strategies.
format Article
id doaj-art-36b030e63cf14d07af0bd143111de591
institution OA Journals
issn 1479-5876
language English
publishDate 2025-05-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj-art-36b030e63cf14d07af0bd143111de5912025-08-20T01:53:19ZengBMCJournal of Translational Medicine1479-58762025-05-0123111810.1186/s12967-025-06537-9AP5Z1 affects hepatocellular carcinoma growth and autophagy by regulating PTEN ubiquitination and modulating the PI3K/Akt/mTOR pathwayZhipeng Quan0Bo Peng1Kai Hu2Lixing Liang3Mingjiang Liu4Lijuan Liao5Shilian Chen6Jing Qin7Songqing He8Zeyuan Li9Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDivision of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityGuangxi Key Laboratory of Immunology and Metabolism for Liver DiseasesGuangxi Key Laboratory of Immunology and Metabolism for Liver DiseasesDivision of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDivision of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDivision of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityGuangxi Key Laboratory of Immunology and Metabolism for Liver DiseasesDivision of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDivision of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityAbstract Background Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, with high incidence and mortality rates, and the number of cases is expected to increase by 2030. Understanding the molecular mechanisms of HCC and identifying new therapeutic targets and biomarkers for HCC are crucial. Methods In this study, we examined adaptor-related protein complex 5 subunit ζ1 (AP5Z1) expression in liver cancer and nearby noncancerous tissues to explore its effects on HCC cell growth, death, and autophagy. The functional and molecular mechanisms of AP5Z1 were studied using clinical sample analysis, Western blot (WB), immunohistochemistry (IHC), quantitative reverse-transcription polymerase chain reaction (qRT‒PCR), coimmunoprecipitation (Co-IP), cell proliferation assays, flow cytometry (FCM), autophagy assays, electron microscopy, mass spectrometry (MS), transcriptome analysis, and animal model experiments. Results AP5Z1 expression was notably higher in HCC tissues than in normal tissues and was linked to a poor prognosis. The results of both in vitro and in vivo studies revealed that AP5Z1 promoted HCC cell growth and reduced apoptosis. In addition, AP5Z1 regulates cellular autophagy by ubiquitinating the phosphatase and tensin homolog (PTEN) protein and modulating the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway. Conclusions AP5Z1 influences autophagy and apoptosis in HCC cells by interacting with PTEN to modulate the PI3K/Akt/mTOR pathway. This gene might promote PTEN ubiquitination and degradation by recruiting tripartite motif-containing protein 21 (TRIM21), making it a potential biomarker for diagnosing and predicting the outcome of HCC as well as a target for new treatment strategies.https://doi.org/10.1186/s12967-025-06537-9Hepatocellular carcinomaAP5Z1PTENTRIM21AutophagyApoptosis
spellingShingle Zhipeng Quan
Bo Peng
Kai Hu
Lixing Liang
Mingjiang Liu
Lijuan Liao
Shilian Chen
Jing Qin
Songqing He
Zeyuan Li
AP5Z1 affects hepatocellular carcinoma growth and autophagy by regulating PTEN ubiquitination and modulating the PI3K/Akt/mTOR pathway
Journal of Translational Medicine
Hepatocellular carcinoma
AP5Z1
PTEN
TRIM21
Autophagy
Apoptosis
title AP5Z1 affects hepatocellular carcinoma growth and autophagy by regulating PTEN ubiquitination and modulating the PI3K/Akt/mTOR pathway
title_full AP5Z1 affects hepatocellular carcinoma growth and autophagy by regulating PTEN ubiquitination and modulating the PI3K/Akt/mTOR pathway
title_fullStr AP5Z1 affects hepatocellular carcinoma growth and autophagy by regulating PTEN ubiquitination and modulating the PI3K/Akt/mTOR pathway
title_full_unstemmed AP5Z1 affects hepatocellular carcinoma growth and autophagy by regulating PTEN ubiquitination and modulating the PI3K/Akt/mTOR pathway
title_short AP5Z1 affects hepatocellular carcinoma growth and autophagy by regulating PTEN ubiquitination and modulating the PI3K/Akt/mTOR pathway
title_sort ap5z1 affects hepatocellular carcinoma growth and autophagy by regulating pten ubiquitination and modulating the pi3k akt mtor pathway
topic Hepatocellular carcinoma
AP5Z1
PTEN
TRIM21
Autophagy
Apoptosis
url https://doi.org/10.1186/s12967-025-06537-9
work_keys_str_mv AT zhipengquan ap5z1affectshepatocellularcarcinomagrowthandautophagybyregulatingptenubiquitinationandmodulatingthepi3kaktmtorpathway
AT bopeng ap5z1affectshepatocellularcarcinomagrowthandautophagybyregulatingptenubiquitinationandmodulatingthepi3kaktmtorpathway
AT kaihu ap5z1affectshepatocellularcarcinomagrowthandautophagybyregulatingptenubiquitinationandmodulatingthepi3kaktmtorpathway
AT lixingliang ap5z1affectshepatocellularcarcinomagrowthandautophagybyregulatingptenubiquitinationandmodulatingthepi3kaktmtorpathway
AT mingjiangliu ap5z1affectshepatocellularcarcinomagrowthandautophagybyregulatingptenubiquitinationandmodulatingthepi3kaktmtorpathway
AT lijuanliao ap5z1affectshepatocellularcarcinomagrowthandautophagybyregulatingptenubiquitinationandmodulatingthepi3kaktmtorpathway
AT shilianchen ap5z1affectshepatocellularcarcinomagrowthandautophagybyregulatingptenubiquitinationandmodulatingthepi3kaktmtorpathway
AT jingqin ap5z1affectshepatocellularcarcinomagrowthandautophagybyregulatingptenubiquitinationandmodulatingthepi3kaktmtorpathway
AT songqinghe ap5z1affectshepatocellularcarcinomagrowthandautophagybyregulatingptenubiquitinationandmodulatingthepi3kaktmtorpathway
AT zeyuanli ap5z1affectshepatocellularcarcinomagrowthandautophagybyregulatingptenubiquitinationandmodulatingthepi3kaktmtorpathway